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Erratum
This article mistakenly reports the delivery agent in electronic cigarettes as diethylene glycol instead of
propylene glycol. Propylene glycol is a relatively benign substance commonly used in concert smoke
machines. Diethylene glycol, a highly toxic substance, was reportedly found in only one e-cigarette
cartridge studied in the literature, which may have been due to use of a nonpharmaceutical grade
propylene glycol. JPCRR regrets this error.
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Abstract

Data from a randomized controlled trial and systematic review
support the claim that switching from tobacco cigarettes to
electronic cigarettes (e-cigarettes) can reduce the short-term
negative health effects of smoking. In adult smokers unwilling
or unable to quit, exhaled carbon monoxide levels, total
number of cigarettes smoked, and exposure to nitrosamine
chemicals were reduced within a 12-month period. While
the e-cigarette industry remains largely unregulated thus far,
these studies provide encouraging hope in the uphill battle
toward helping patients make informed and healthy choices.
(J Patient-Centered Res Rev. 2014;1:99-101.)
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Clinical Question

In adult smokers unwilling or unable to quit, does changing
from tobacco cigarettes to electronic cigarettes decrease the
negative health effects associated with smoking tobacco?

Answer

Probably, based on current evidence. More research is needed.
Date answer was determined: December 2013
Level of evidence for the answer: A
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Inclusion Criteria

Published systematic reviews, meta-analyses, randomized
controlled trials and cohort studies comparing the shortterm and relatively long-term health effects of electronic
cigarettes with tobacco cigarettes.

Exclusion Criteria

Pregnant women, children, and individuals with preexisting
lung disease.

Summary of the Issues

Tobacco use is projected to kill 1 billion people in the 21st
century, making it the single greatest cause of preventable
death globally.1 Tobacco use in any form has negative health
consequences, the severity of which depends on the amount
and duration of smoking as well as the type of nicotine
delivery system employed.1 Tobacco cigarette smoke
contains thousands of chemical byproducts (including 45
known or suspected carcinogens) that bind to DNA causing
genetic mutations. Tobacco also contains nicotine, a highly
addictive and psychoactive drug.
Electronic cigarettes (e-cigarettes) or electronic nicotine
delivery systems, first introduced in China in 2006, have spread
worldwide.2 Often made to resemble traditional cigarettes,
e-cigarettes vaporize a solution containing nicotine and flavor
in an agent such as diethylene glycol. The result is a relatively
clean nicotine delivery system that should, in theory, have
fewer adverse health effects when compared with traditional
cigarettes. However, extensive data is lacking, and there remain
significant concerns regarding the purity of the ingredients,
device functionality, user modification and general lack of
oversight regarding manufacturing and marketing.2
As popularity of e-cigarettes continues to increase, studies
comparing the effects of e-cigarettes and traditional cigarettes
on acute adverse health outcomes are emerging.3 This data is
essential for recommending their use, particularly in smokers
unwilling or unable to quit. The Jan. 8, 2014, tobacco-themed
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issue of The Journal of the American Medical Association
focused on a number of different challenges that health care
providers have encountered in the last 50 years regarding
tobacco abuse and cessation attempts, and included a call for
more research and regulation of e-cigarettes.4

Summary of the Evidence

Studies have shown that risks of these negative health effects
are related to the length of time a person smokes and how
much they smoke.1 As such, we chose to infer that reducing
the extent and duration of tobacco cigarette smoking would, in
turn, decrease these negative health effects. While more than
100 online and print publications were reviewed, only one
randomized control trial was found that studied e-cigarette
use in smokers unwilling or unable to quit.5 Various other
publications that studied the safety of e-cigarettes referenced
each other, and we chose to use information from two of the
most comprehensive resources.3,5
Since long-term effects of e-cigarettes are unavailable, we
chose to focus on measurable physiological and chemical
parameters that have been scientifically linked to adverse
health effects of smoking. Nitrosamine is a chemical
compound found in latex, rubber, cosmetics and pesticides,
as well as in tobacco smoke, snuff and snus, a moist powdery
variation of snuff.3 More than 90% of nitrosamine derivatives
are known to be highly carcinogenic and have been shown
to cause a wide range of cancers.3 Carbon monoxide (CO),
another byproduct of the combustion process, reduces the
body’s oxygen-carrying capacity and alveolar elasticity,
promoting the development of emphysema and chronic
obstructive pulmonary disease.3
Cahn et al.,3 examining the evidence concerning the safety
and efficacy of e-cigarettes, stated that only a minority (5,300
of the 10,000-100,000) of the chemicals in cigarette smoke
have been detected, whereas all components in e-cigarette
vapor have been identified using gas chromatography and
mass spectrometry. Only two substances in e-cigarettes
(nitrosamines and diethylene glycol) are believed to have
negative health effects. The researchers noted that maximal
levels of nitrosamine in e-cigarettes are comparable to those
in a nicotine patch and are much lower than in tobacco
cigarettes (Table 1).3 Diethylene glycol is a relatively benign
substance commonly used in concert smoke machines, but it
also has been associated with lethal toxicity at high levels.6

Table 1. Nitrosamine levels in various nicotine delivery systems3
Nicotine delivery systems

Nitrosamine
level*

Nicotine gum (4 mg)

2.00

Nicotine patch (4 mg)

8.00

Electronic cigarettes

8.18

Snus (moist powdery smokeless tobacco)

~2,010

Light cigarettes

~4,800

Full-strength cigarettes

~6,200

Dipping or smokeless tobacco (straight long cut)

~9,300

*Levels are reported as total nanograms in 1 gram of product.

(n=100 each) received nicotine cartridges of different
strengths; the third group (n=100) received non-nicotine
cartridges for 12 weeks. Participants were not required to
change their current smoking habits.
Over the 12-month period, nine follow-up visits were used
to determine number of cigarettes smoked daily and exhaled
CO levels. Both parameters decreased in the groups using
e-cigarettes (Figure 1). A significant number of “reducers”
(smokers who reduced daily cigarette use by more than
50%) and “quitters” (those abstaining from smoking and had
exhaled CO level <7 ppm) did not experience side effects
commonly associated with quitting tobacco smoking. Rates
of hunger (6.5%), insomnia (4%), irritability (3.5%), anxiety
(3%) and depression (2%) were lower than that expected
with traditional tobacco smoking cessation methods.4 In
addition, no weight gain was reported during this study.
Even though it is a relatively clean nicotine delivery system,
e-cigarettes still contain nicotine. Nicotine is an addictive
and psychoactive agent that causes physical dependence
and tolerance while enhancing attention, concentration
Figure 1. Amount of exhaled carbon monoxide (in parts per
million) and total cigarettes per day in electronic cigarette users
that are unwilling to quit tobacco cigarette use.5

Caponnetto et al.5 designed a 12-month, prospective,
randomized controlled trial to evaluate smoking reduction
and/or abstinence among 300 smokers unwilling to quit
using two different nicotine strength e-cigarettes: 2 groups
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and mood. It is also a sympathomimetic drug that releases
catecholamines, increasing heart rate and blood pressure,
constricting blood vessels and reducing sensitivity to
insulin.1 Nicotine thus has its own negative health effects,
but long-term use of nicotine replacement products (gum,
patch, etc.) have been shown to be generally well tolerated
without evidence of serious adverse consequences.1

Conclusion

In tobacco smokers unwilling to quit, switching to e-cigarettes
decreases exhaled CO level and number of tobacco cigarettes
smoked. Furthermore, users of e-cigarettes are exposed
to less carcinogenic nitrosamine than tobacco cigarette
smokers. A reduction in exposure to CO and nitrosamines,
as well as an overall reduction in smoking, helps reduce
smoking-related negative health effects.
However, further studies are needed to evaluate the longand short-term effects of the diethylene glycol chemicals
used as delivery agents in e-cigarettes. Improved product
regulation and standardization of nicotine levels, safety, use
and commercialization are required before e-cigarettes can be
called a “safe” alternative to tobacco cigarette smoking.4 In the
meantime, these early studies shed exciting new information on
an addiction that has defied traditional treatment approaches.
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